Tango Therapeutics director Robert Azelby files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Tango Therapeutics director Robert Azelby filed an initial Form 3 beneficial ownership statement on June 19. The original content was published via EDGAR by Tango Therapeutics Inc. on June 23, 2026.
- Tango Therapeutics director Robert Azelby filed an initial Form 3 statement on June 19. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-279866), on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here